Project 1: Diagnose high-grade ovarian serous carcinoma precursors and occult tumors
- Institution
- Johns Hopkins University, MD
- Principal investigator
- Nickolas Papadopoulos
- Funding
- $300K
- Duration
- 2018–2029
Moonbase score
Still being scored
Abstract
Abstract (Project 1) The objective is to streamline the detection of incidental occult ovarian carcinoma and its precursor lesions in fallopian tubes, which are the site of origin of “ovarian” high-grade serous carcinoma (HGSC). The updated paradigm in the genesis of ovarian HGSC posits that tumor initiation occurs in the fallopian tube epithelium through a precursor stage, serous tubal intraepithelial carcinoma (STIC). Women at high risk for ovarian cancer are up to 20-35 times more likely to develop HGSC in their lifetime. The current recommendation for these women is to undergo risk-reduction salpingo-oophorectomy (RRSO) after their childbearing age. This procedure reduces but does not eliminate HGSC risk entirely because STIC or occult HGSC cells may have spread to the peritoneum prior to surgery, portending a recurrence of an advanced stage disease. The current standard-of- care diagnosis is based on examining surgically removed fallopian tubes. Since the lesions are grossly inconspicuous, pathologists randomly section tubes and review only limited representative tissue sections, precluding an accurate diagnosis and often failing to predict clinical outcome. Project 1 aims to apply Real-SeqS and DREAMing in assessing STIC/HGSC specific aneuploidy patterns and methylation markers, respectively, to sensitively diagnose STICs and incipient HGSC in RRSO specimens after brushing the surface of tubes and ovaries to collect epithelial cells for Real-SeqS and DREAMing analyses. We propose the following two specific aims. Aim 1. Assess the performance of Real-SeqS and DREAMing using tubal brushing specimens from prospective RRSO specimens. Aim 2. Using several cutting-edge methods, assess the prioritized amplified cancer genes including CCNE1 and RSF1 for their cancer-spreading phenotypes including proliferation, motility, invasion, and tumor-forming ability in peritoneal tissues. This project springboards from several recent studies published by current SPORE.
LOADING MOONBASE SCORE
Questions for Johns Hopkins University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Johns Hopkins UniversityNot yet scored
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids
Nishant Agrawal · $709K · 2018–2028
- NIH · Johns Hopkins University72
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
Elham Hatef-Naimi · $611K · 2021–2025
- NIH · Johns Hopkins University66
Glucose instability and neurocognitive outcomes in older adults
Elizabeth Selvin · $697K · 2021–2027